Summary & Overview
CPT 0556U: Respiratory Pathogen PCR Panel (HealthTrackRx)
CPT code 0556U designates a Proprietary Laboratory Analyses (PLA) test — specifically the HealthTrackRx respiratory pathogen panel from Thermo Fisher Scientific. The assay uses real-time PCR with a reverse transcription step to detect DNA or RNA from up to 12 bacterial and viral respiratory pathogens on a nasal or throat swab. PLA codes like 0556U are unique to a single manufacturer or laboratory, which matters for payer coverage, lab contracting, and reporting. Nationally, molecular respiratory testing remains central to infectious disease surveillance, treatment decisions, and outpatient care pathways.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical application of the test, the service setting, and payer considerations affecting coverage and billing. The publication outlines benchmark topics such as common reimbursement frameworks for PLA codes, coding and billing practice implications for laboratories and providers, and the clinical context for ordering a multi-pathogen respiratory PCR with RT. Data limitations: Data not available in the input for specific coverage policies, negotiated rates, associated taxonomies, ICD-10 diagnoses, and related codes.
Billing Code Overview
CPT code 0556U is a Proprietary Laboratory Analyses (PLA) code that applies exclusively to the HealthTrackRx test from Thermo Fisher Scientific. The assay detects bacterial and viral pathogens in the respiratory tract using real-time polymerase chain reaction (PCR) with a reverse transcription step to convert RNA into DNA, allowing RNA viruses to be analyzed. The test evaluates up to 12 distinct pathogens and reports each result as either detected or not detected. The specimen is collected via a nasal or throat swab.
Service type: Molecular diagnostic respiratory pathogen panel (real-time PCR with RT step)
Typical site of service: Clinical laboratory or outpatient specimen collection site (nasal/throat swab collection)
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult or pediatric outpatient presenting to a primary care clinic, urgent care, emergency department, or community testing site with acute respiratory symptoms such as cough, sore throat, nasal congestion, fever, or shortness of breath. A clinician obtains a nasopharyngeal, nasal mid-turbinate, anterior nasal, or oropharyngeal swab and orders the proprietary HealthTrackRx test (0556U) from Thermo Fisher Scientific to detect a panel of viral and bacterial respiratory pathogens. The specimen is sent to the performing laboratory where RNA viruses are subjected to reverse transcription followed by real-time PCR to detect target nucleic acids. Results are reported as “detected” or “not detected” for each of the 12 pathogens. Typical workflow steps include patient evaluation, specimen collection, labeling and transport to the reference laboratory, PCR testing with reverse transcription as required, result verification, and clinician notification for treatment or infection control decisions. Typical sites of service include outpatient clinics, urgent care centers, emergency departments, and reference laboratories performing high-complexity molecular testing.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Procedure has not been modified | Use when no modifier is required and the service was performed under routine circumstances. |